On the anticonvulsant activity of kaurenic acid

Investigacion Clinica

Volumn 48, Issue 3, 2007, Pages 349-358

  Daló, Nelson L ^a   Sosa Sequera, Miriam C ^a   Usubillaga, Alfredo ^b  

^a UNIVERSIDAD CENTROCCIDENTAL LISANDRO ALVARADO   (Venezuela)

^b UNIVERSIDAD DE LOS ANDES   (Venezuela)

Author keywords

Anticonvulsant; Diterpenes; Kaurenic acid; Seizure; Sudden cooling

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; KAURENIC ACID; PENTETRAZOLE; PHENYTOIN; UNCLASSIFIED DRUG; VALPROIC ACID; ARGYROPHILIC ACID; DITERPENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; MOUSE; NONHUMAN; SEIZURE; ANIMAL; CHEMICALLY INDUCED DISORDER; COLD; COMPARATIVE STUDY; DISEASE MODEL; DRUG SCREENING; HINDLIMB; INNERVATION; MUSCLE CONTRACTION; MUSCLE WEAKNESS; PATHOLOGICAL REFLEX; SPINAL CORD; TOAD;

ANIMALS; ANTICONVULSANTS; BUFO MARINUS; COLD; DISEASE MODELS, ANIMAL; DITERPENES; DRUG EVALUATION, PRECLINICAL; HINDLIMB; MICE; MUSCLE CONTRACTION; MUSCLE WEAKNESS; PENTYLENETETRAZOLE; REFLEX, ABNORMAL; SEIZURES; SPINAL CORD;

EID: 38149021535     PISSN: 05355133     EISSN: 05355133     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Sano M, Seto-Ohshima A, Mizutani A. Forskolin suppresses seizure induced by pentylenetetrazol in mice. Experientia 1984; 40:1271-1272.
2. Seamon KB, Padgett W, Daly JW. Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci 1981; 78: 3363-3367.
3. Georgieva J. Effect of diterpene sclareol glycol on convulsive seizures. Methods Find
4. Ameri A, Gleitz J, Peter T. Bicuculline-induced epileptiform activity in rat hippocampal slices: suppression by Aconitum alkaloids. Planta Med 1997; 63: 228-232.
5. Higashima M, Ohno K, Koshino Y. Cyclic AMP-mediated modulation of epileptiform afterdischarge generation in rat hippocampal slices. Brain Res 2002; 949: 157-161.
6. Usubillaga A, Capra MC. Chemical constituents of Espeletia semiglobulata. Fitoterapia 1988; 59:382-384.
7. Usubillaga A, Romero M, Aparicio R. Kaurenic acid in Espeletiinae. Acta Hortic 2003; 597: 129-130.
8. Davino SC, Giesbrecht AM, Roque NF. Antimicrobial activity of kaurenoic acid derivatives substituted on carbon-15. Braz J Med Biol Res 1989; 22:1127-1129.
9. Ohkoshi E, Makino M, Fujimoto Y. Studies on the constituents of Mikania hirsutissima (Compositae). Chem Pharm Bull (Tokyo), 1999; 47: 1436-1438.
10. Schwaiger S, Adams M, Seger C, Elimerer EP, Bauer R, Stuppner H. New constituents of Leontopodium alpinum and their in vitro leukotriene biosynthesis inhibitory activity. Planta Med 2004; 70:978-985.
11. Daló NL, Larson AA. Spinal seizures evoked by sudden cooling of amphibian isolated spinal cords: involvement of excitatory amino acids. Cryobiology 1991; 28:255-267.
12. Daĺo NL, Bracho GA, Piña-Crespo JC. Motor impairment and neuronal damage following hypothermia in tropical amphibians. Int J Exp Pathol 2007; 88(1):1-7.
13. Piña-Crespo JC, Daló NL. Activity of common anticonvulsant drugs on spinal seizure-induced by sudden cooling. Prog Neuro-Psychopharmacol Biol Psychiatry 2006; 30:1202-1208.
14. Cortez MA, Snead OC III. Pharmacologic models of generalized absence seizures in rodents. In: Pitkanen A, Schwartzkroin PA, Moshe SL, Eds. Model of seizures and epilepsy, Elsevier Inc, 2006, p 111-126.
15. Koella WP. Animal experimental models in the study of antiepileptic drugs. In. Frey HH, Yanz D, Eds. Handbook of Experimental Pharmacology, Springer, Berlin, 1985; 74: p 281-339.
16. Fisher RS. Animal models of the epilepsies. In: Fisher RS, Coyle JC, Eds. Neurotransmitter and Epilepsy, Wiley-Liss; 1991, p 61-76.
17. Loscher W, Honack D, Fassbender P, Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentyllenetetrazole seizure models. Epilepsy Res 1991; 8:171-189.
18. Daĺo NL, Hackman JC, Davidoff RA. Motoneuron depolarization, paroxysmal activity and reflex changes induced by rapid cooling of toad spinal cord. Comp Biochem Physiol 1995; 112A:517-525.
19. Daĺo NL, Piña-Crespo JC. Ketamine abolishes the tonic phase of the seizures evoked by sudden cooling of toad isolated spinal cords. Neuropharmacology 1992; 31:509-512.
20. Georgieva J, Danchev N. The effect of diterpene sclareol on seizure do not depend on central benzodiazepine receptors. Methods Find Exp Clin Pharmacol 1990; 12: 679-683.
21. Neira N, Usubillaga A, Linarez G, Escobar A, Mujica F, Testa M, Sosa-Sequera M. Vasorelaxant effect of sodium kaurenate: a possible nitric oxide-releasing agent (Abstract). Biocell 2003; 27(Suppl. 3):392.
22. Wojtal K, Gniatkowska-Nowakowska A, Czuczwar SJ. Is nitric oxide involved in the anticonvulsant action of antiepileptic drugs?. Polish J. Pharmacol 2003; 55: 535-542.
23. Kuputlu I, Uzbay T. L-NAME inhibits pentylenetetrazol and strychnine-induced seizures in mice. Brain Res 1997; 753:98-101.